Trendlines is an innovation commercialization company that invents, discovers, invests in, and incubates innovation-based medical and agricultural technologies to fulfill its mission to improve the human condition. As intensely hands-on investors, Trendlines is involved in all aspects of its portfolio companies from technology development to business building. Trendlines’ shares are traded on the Singapore Stock Exchange (SGX: 42T) and in the United States as an American Depositary Receipt (ADR) on the OTCQX (OTCQX: TRNLY).

The Trendlines Group announced today that during 2018 and the first six months of 2019 five of its portfolio companies were chosen to receive prestigious Horizon 2020 grants.

Horizon 2020 is “the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.”


Only a small percentage of applicants receive grants for “world-class science,” company leadership, and solutions that “tackle societal challenges.”

According to an EU study released in December 2017, only 12.6% of applications were approved in the program’s first three years.

Through the program, Israeli researchers, start-ups, and innovators have gained access to European partners and the extensive European research infrastructure.

These Trendlines portfolio companies received Horizon 2020 grants, each exceeding € 1 million:

Saturas Ltd. developed an Advanced Decision Support System (ADSS) for precision irrigation based on its miniature Stem Water Potential (SWP) sensor.

GreenSpense Ltd. developed a gas-free, high-pressure continuous dispensing solution based on breakthroughs in elastomer technology and materials engineering.

ElastiMed Ltd. developed a device using smart material-based technology mimicking rhythmic calf muscle contractions to improve circulation.

ProArc Medical Ltd. developed the ClearRing solution intended to treat symptoms due to urinary outflow obstruction caused by enlarged prostate also known as BPH (Benign Prostatic Hyperplasia).

liberDi Ltd. developed an all-in-one portable dialysis device providing scalable digital and safe self-care anywhere.


steverhodes talk1.16Trendlines Chairman & CEO Steve Rhodes.
NextInsight file photo.
Trendlines Chairman and CEO Steve Rhodes commented, “We’re extremely proud of the companies that received non-dilutive funding grants through Horizon 2020 indicating a strong endorsement of their technological progress and promise. The grants affirm the companies’ excellence and innovation in their respective fields and provide funding to assist them in bringing their technologies to market.”

You may also be interested in:


You have no rights to post comments

Counter NameLastChange
AEM Holdings2.3700.030
Best World2.460-
Boustead Singapore0.945-0.015
Broadway Ind0.133-
China Aviation Oil (S)0.920-0.005
China Sunsine0.4200.005
ComfortDelGro1.480-
Delfi Limited0.895-
Food Empire1.260-
Fortress Minerals0.300-0.005
Geo Energy Res0.305-0.005
Hong Leong Finance2.500-
Hongkong Land (USD)3.1400.020
InnoTek0.5500.030
ISDN Holdings0.305-0.005
ISOTeam0.0440.001
IX Biopharma0.0420.001
KSH Holdings0.250-
Leader Env0.047-0.004
Ley Choon0.045-
Marco Polo Marine0.067-
Mermaid Maritime0.139-0.001
Nordic Group0.305-0.005
Oxley Holdings0.088-0.001
REX International0.133-0.003
Riverstone0.795-0.020
Southern Alliance Mining0.430-
Straco Corp.0.485-0.025
Sunpower Group0.2100.005
The Trendlines0.067-
Totm Technologies0.022-
Uni-Asia Group0.820-0.005
Wilmar Intl3.470-0.030
Yangzijiang Shipbldg1.740-0.010
 

We have 644 guests and no members online

rss_2 NextInsight - Latest News